Abstract
Immunotoxicology is the study of immune system dysfunction that can result from occupational, inadvertent, or therapeutic exposure to a variety of chemical or biologic agents that alter the immune system and affect human health. Immunotoxicology can manifest in a variety of ways, with one of the most prominent effects being immunosuppression. Immunosuppression can be defined as a reduced ability of the immune system to respond to a challenge from a level considered normal, regardless of whether clinical disease results. Although immunosuppression can lead to an increased incidence and severity of infectious and neoplastic disease, interpreting data from experimental immunotoxicology studies, or even epidemiologic studies, for quantitative risk assessment has been a persistent challenge. Decades of research has resulted in the development of specific assays and the identification of sensitive endpoints that measure effects on the immune response, from which many regulatory agencies have developed specific immunotoxicity testing guidelines. However, establishing a direct link between exposure and disease manifestations for immunosuppression in humans is an ongoing challenge due to inherent limitations of epidemiological studies to draw causal conclusions. Efforts have been made to examine the relationships between laboratory measures of immune response and disease resistance in experimental animal models and also in human studies. The identification of sensitive endpoints and the development of experimental assays to identify suspect immunotoxicants are a primary focus of the field of immunotoxicology. This chapter is organized around sections discussing the impact and scientific basis of immunotoxicity testing, predictive immunotoxicity testing strategies, examples of immunotoxicity testing, and key considerations and recent developments related to effective testing strategies for health risk reduction.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Luster MI, Rosenthal GJ (1993) Chemical agents and the immune response. Environ Health Perspect 100:219–226
Veraldi A, Costantini AS, Bolejack V, Miligi L, Vineis P, van Loveren H (2006) Immunotoxic effects of chemicals: a matrix for occupational and environmental epidemiological studies. Am J Ind Med 49:1046–1055
Ehrke MJ (1991) Effect of cancer therapy on host response and immunobiology. Curr Opin Oncol 3:1070–1077
Malat G, Culkin C (2016) The ABCs of immunosuppression: a primer for primary care physicians. Med Clin North Am 100:505–518
Luster MI (2014) A historical perspective of immunotoxicology. J Immunotoxicol 11:197–202
DeWitt JC, Germolec DR, Luebke RW, Johnson VJ (2016) Associating changes in the immune system with clinical diseases for interpretation in risk assessment. Curr Protoc Toxicol 67:18.11.11–18.11.22
Dean JH, Luster MI, Boorman GA, Lauer LD (1982) Procedures available to examine the immunotoxicity of chemicals and drugs. Pharmacol Rev 34:137–148
Luster MI, Munson AE, Thomas PT, Holsapple MP, Fenters JD, White KL Jr, Lauer LD, Germolec DR, Rosenthal GJ, Dean JH (1988) Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam Appl Toxicol 10:2–19
Luster MI, Portier C, Pait DG, White KL Jr, Gennings C, Munson AE, Rosenthal GJ (1992) Risk assessment in immunotoxicology. I Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18:200–210
Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P, Kouchi Y, Craig W et al (1993) Risk assessment in immunotoxicology. II Relationships between immune and host resistance tests. Fundam Appl Toxicol 21:71–82
House RV (2010) Fundamentals of clinical immunotoxicology. In: Dietery RR (ed) Immunotoxicity testing. Humana Press, Totowa, NJ, pp 363–384
EPA U (2007) Environmental protection agency, 40 CFR parts 9 and 158. Pesticides: data requirement for conventional chemicals. Fed Regist 72(207):60934–60988
Tryphonas H (2001) Approaches to detecting immunotoxic effects of environmental contaminants in humans. Environ Health Perspect 109(Suppl 6):877–884
ALA (American Lung Association) (2010) Influenza and pneumonia: state of lung disease in diverse communities. ALA, Washington, DC
Heron M (2013) Death: leading causes for 1020. Natl Vital Stat Rep 62: National Center for Health Statistics. Hyattsville, MD
Voirin N, Barret B, Metzger MH, Vanhems P (2009) Hospital-acquired influenza: a synthesis using the outbreak reports and intervention studies of nosocomial infection (ORION) statement. J Hosp Infect 71:1–14
Sartor C, Zandotti C, Romain F, Jacomo V, Simon S, Atlan-Gepner C, Sambuc R, Vialettes B, Drancourt M (2002) Disruption of services in an internal medicine unit due to a nosocomial influenza outbreak. Infect Control Hosp Epidemiol 23:615–619
Corsini E, Sokooti M, Galli CL, Moretto A, Colosio C (2013) Pesticide induced immunotoxicity in humans: a comprehensive review of the existing evidence. Toxicology 307:123–135
Kramer S, Hikel SM, Adams K, Hinds D, Moon K (2012) Current status of the epidemiologic evidence linking polychlorinated biphenyls and non-hodgkin lymphoma, and the role of immune dysregulation. Environ Health Perspect 120:1067–1075
Boverhof DR, Ladics G, Luebke B, Botham J, Corsini E, Evans E, Germolec D, Holsapple M, Loveless SE, Lu H, van der Laan JW, White KL Jr, Yang Y (2014) Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary. Regul Toxicol Pharmacol 68:96–107
Van Loveren H, Van Amsterdam JG, Vandebriel RJ, Kimman TG, Rumke HC, Steerenberg PS, Vos JG (2001) Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect 109:757–764
Weisglas-Kuperus N, Patandin S, Berbers GA, Sas TC, Mulder PG, Sauer PJ, Hooijkaas H (2000) Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect 108:1203–1207
Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T (2014) Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci 138:76–88
Granum B, Haug LS, Namork E, Stolevik SB, Thomsen C, Aaberge IS, van Loveren H, Lovik M, Nygaard UC (2013) Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 10:373–379
OECD (2005) Results of survey on production and use of PFOS and PFOA, related substances and products/mixtures containing these substances. Organisation for Economic Co-operation and Development, Paris
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL (2007) Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and nutrition examination survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect 115:1596–1602
Steenland K, Fletcher T, Savitz DA (2010) Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100–1108
Barry V, Winquist A, Steenland K (2013) Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121:1313–1318
Steenland K, Woskie S (2012) Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 176:909–917
Steenland K, Zhao L, Winquist A (2015) A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occup Environ Med 72:373–380
Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, Zobel LR (2004) Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 39:363–380
Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM (2006) Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 48:771–779
Brieger A, Bienefeld N, Hasan R, Goerlich R, Haase H (2011) Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes. Toxicol In Vitro 25:960–968
Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, Heilmann C (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307:391–397
Dewitt JC, Copeland CB, Strynar MJ, Luebke RW (2008) Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect 116:644–650
Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Moller G, Nelson BD, DePierre JW (2002) Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2:389–397
Vos J, Van Loveren H, Wester P, Vethaak D (1989) Toxic effects of environmental chemicals on the immune system. Trends Pharmacol Sci 10:289–292
Lu YC, Wu YC (1985) Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ Health Perspect 59:17–29
Jusko TA, De Roos AJ, Lee SY, Thevenet-Morrison K, Schwartz SM, Verner MA, Murinova LP, Drobna B, Kocan A, Fabisikova A, Conka K, Trnovec T, Hertz-Picciotto I, Lawrence BP (2016) A birth cohort study of maternal and infant serum PCB-153 and DDE concentrations and responses to infant tuberculosis vaccination. Environ Health Perspect 124:813–821
Stolevik SB, Nygaard UC, Namork E, Haugen M, Meltzer HM, Alexander J, Knutsen HK, Aaberge I, Vainio K, van Loveren H, Lovik M, Granum B (2013) Prenatal exposure to polychlorinated biphenyls and dioxins from the maternal diet may be associated with immunosuppressive effects that persist into early childhood. Food Chem Toxicol 51:165–172
Ruder AM, Hein MJ, Hopf NB, Waters MA (2017) Cancer incidence among capacitor manufacturing workers exposed to polychlorinated biphenyls. Am J Ind Med 60:198–207
He Y, Peng L, Huang Y, Peng X, Zheng S, Liu C, Wu K (2016) Association of breast adipose tissue levels of polychlorinated biphenyls and breast cancer development in women from Chaoshan, China. Environmental science and pollution research international
Ali I, Julin B, Glynn A, Hogberg J, Berglund M, Johansson JE, Andersson SO, Andren O, Giovannucci E, Wolk A, Stenius U, Akesson A (2016) Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies. Carcinogenesis 37:1144–1151
Tryphonas H (1994) Immunotoxicity of polychlorinated biphenyls: present status and future considerations. Exp Clin Immunogenet 11:149–162
Smialowicz RJ, Andrews JE, Riddle MM, Rogers RR, Luebke RW, Copeland CB (1989) Evaluation of the immunotoxicity of low level PCB exposure in the rat. Toxicology 56:197–211
Fries GF (1985) The PBB episode in Michigan: an overall appraisal. Crit Rev Toxicol 16:105–156
Bekesi JG, Roboz JP, Fischbein A, Mason P (1987) Immunotoxicology: environmental contamination by polybrominated biphenyls and immune dysfunction among residents of the state of Michigan. Cancer Detect Prev Suppl 1:29–37
Roboz J, Greaves J, Bekesi JG (1985) Polybrominated biphenyls in model and environmentally contaminated human blood: protein binding and immunotoxicological studies. Environ Health Perspect 60:107–113
Bekesi JG, Holland JF, Anderson HA, Fischbein AS, Rom W, Wolff MS, Selikoff IJ (1978) Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science (New York, NY) 199:1207–1209
Bekesi JG, Anderson HA, Roboz JP, Roboz J, Fischbein A, Selikoff IJ, Holland JF (1979) Immunologic dysfunction among PBB-exposed Michigan dairy farmers. Ann N Y Acad Sci 320:717–728
Bekesi JG, Roboz J, Anderson HA, Roboz JP, Fischbein AS, Selikoff IJ, Holland JF (1979) Impaired immune function and identification of polybrominated biphenyls (PBB) in blood compartments of exposed Michigan dairy farmers and chemical workers. Drug Chem Toxicol 2:179–191
Luster MI, Faith RE, Moore JA (1978) Effects of polybrominated biphenyls (PBB) on immune response in rodents. Environ Health Perspect 23:227–232
Fraker PJ (1980) The antibody-mediated and delayed type hypersensitivity response of mice exposed to polybrominated biphenyls. Toxicol Appl Pharmacol 53:1–7
Luebke RW, Chen DH, Dietert R, Yang Y, King M, Luster MI (2006) The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B Crit Rev 9:1–26
Kim HA, Kim EM, Park YC, Yu JY, Hong SK, Jeon SH, Park KL, Hur SJ, Heo Y (2003) Immunotoxicological effects of agent Orange exposure to the Vietnam war Korean veterans. Ind Health 41:158–166
Mocarelli P, Marocchi A, Brambilla P, Gerthoux P, Young DS, Mantel N (1986) Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 256:2687–2695
Pocchiari F, Silano V, Zampieri A (1979) Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. Ann N Y Acad Sci 320:311–320
Pocchiari F, Silano V, Zapponi G (1986) The chemical risk management process in Italy. A case study: the Seveso accident. Sci Total Environ 51:227–235
Tognoni G, Bonaccorsi A (1982) Epidemiological problems with TCDD (a critical view). Drug Metab Rev 13:447–469
Baccarelli A, Mocarelli P, Patterson DG Jr, Bonzini M, Pesatori AC, Caporaso N, Landi MT (2002) Immunologic effects of dioxin: new results from Seveso and comparison with other studies. Environ Health Perspect 110:1169–1173
Luster MI, Boorman GA, Dean JH, Harris MW, Luebke RW, Padarathsingh ML, Moore JA (1980) Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Int J Immunopharmacol 2:301–310
Smialowicz RJ, Riddle MM, Williams WC, Diliberto JJ (1994) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats. Toxicol Appl Pharmacol 124:248–256
Kerkvliet NI (2002) Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2:277–291
Luebke R (2012) Immunotoxicant screening and prioritization in the twenty-first century. Toxicol Pathol 40:294–299
Gennari A, Ban M, Braun A, Casati S, Corsini E, Dastych J, Descotes J, Hartung T, Hooghe-Peters R, House R, Pallardy M, Pieters R, Reid L, Tryphonas H, Tschirhart E, Tuschl H, Vandebriel R, Gribaldo L (2005) The use of in vitro Systems for Evaluating Immunotoxicity: the report and recommendations of an ECVAM workshop. J Immunotoxicol 2:61–83
Pessina A, Albella B, Bueren J, Brantom P, Casati S, Gribaldo L, Croera C, Gagliardi G, Foti P, Parchment R, Parent-Massin D, Sibiril Y, Van Den Heuvel R (2001) Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol In Vitro 15:729–740
Fu K, Cheng Q, Liu Z, Chen Z, Wang Y, Ruan H, Zhou L, Xiong J, Xiao R, Liu S, Zhang Q, Yang D (2014) Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells. PLoS One 9:e104426
Croxford AL, Buch T (2011) Cytokine reporter mice in immunological research: perspectives and lessons learned. Immunology 132:1–8
Shepherd DM, Dearstyne EA, Kerkvliet NI (2000) The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4(+) T cells in adoptively transferred mice. Toxicol Sci 56:340–350
DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI (2009) Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39:76–94
Dow LE, Fisher J, O'Rourke KP, Muley A, Kastenhuber ER, Livshits G, Tschaharganeh DF, Socci ND, Lowe SW (2015) Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol 33:390–394
Long CM, Marshall NB, Lukomska E, Kashon ML, Meade BJ, Shane H, Anderson SE (2016) A role for regulatory T cells in a murine model of Epicutaneous toluene Diisocyanate sensitization. Toxicol Sci 152:85–98
Marshall NB, Lukomska E, Nayak AP, Long CM, Hettick JM, Anderson SE (2017) Topical application of the anti-microbial chemical triclosan induces immunomodulatory responses through the S100A8/A9-TLR4 pathway. J Immunotoxicol 14:50–59
Anderson SE, Shane H, Long C, Lukomska E, Meade BJ, Marshall NB (2016) Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride. J Immunotoxicol 13:557–566
Luebke RW, Holsapple MP, Ladics GS, Luster MI, Selgrade M, Smialowicz RJ, Woolhiser MR, Germolec DR (2006) Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process. Toxicol Sci 94:22–27
Hochstenbach K, van Leeuwen DM, Gmuender H, Gottschalk RW, Stolevik SB, Nygaard UC, Lovik M, Granum B, Namork E, Meltzer HM, Kleinjans JC, van Delft JH, van Loveren H (2012) Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns. Toxicol Sci 129:315–324
Hochstenbach K, van Leeuwen DM, Gmuender H, Stolevik SB, Nygaard UC, Lovik M, Granum B, Namork E, van Delft JH, van Loveren H (2010) Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. Toxicol Sci 118:19–30
Shao J, Berger LF, Hendriksen PJ, Peijnenburg AA, van Loveren H, Volger OL (2014) Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol 88:673–689
Motts JA, Shirley DL, Silbergeld EK, Nyland JF (2014) Novel biomarkers of mercury-induced autoimmune dysfunction: a cross-sectional study in Amazonian Brazil. Environ Res 132:12–18
Luster MI, Johnson VJ, Yucesoy B, Simeonova PP (2005) Biomarkers to assess potential developmental immunotoxicity in children. Toxicol Appl Pharmacol 206:229–236
Kopriva SE, Chiasson VL, Mitchell BM, Chatterjee P (2013) TLR3-induced placental miR-210 down-regulates the STAT6/Interleukin-4 pathway. PLoS One 8:e67760
Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839–845
Qi J, Qiao Y, Wang P, Li S, Zhao W, Gao C (2012) microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett 586:1201–1207
Taganov KD, Boldin MP, Baltimore D (2007) MicroRNAs and immunity: tiny players in a big field. Immunity 26:133–137
Xiao C, Rajewsky K (2009) MicroRNA control in the immune system: basic principles. Cell 136:26–36
Anderson SE, Beezhold K, Lukomska E, Richardson J, Long C, Anderson K, Franko J, Meade BJ, Beezhold DH (2014) Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitization. J Immunotoxicol 11:250–259
Burleson FG, Burleson GR (2010) Host resistance assays including bacterial challenge models. Methods Mol Biol 598:97–108
Disclaimer
The findings and conclusion in this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Anderson, S.E., Shane, H.L. (2018). Investigative Immunotoxicology. In: DeWitt, J., Rockwell, C., Bowman, C. (eds) Immunotoxicity Testing. Methods in Molecular Biology, vol 1803. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8549-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8549-4_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8548-7
Online ISBN: 978-1-4939-8549-4
eBook Packages: Springer Protocols